Current status of fenfluramine/dexfenfluramine-induced cardiac valvulopathy.

  title={Current status of fenfluramine/dexfenfluramine-induced cardiac valvulopathy.},
  author={Thomas J. Pallasch},
  journal={Journal of the California Dental Association},
  volume={27 5},
Since publication of the U.S. Department of Health and Human Services' interim recommendations in November 1997 for the management of patients having taken certain appetite suppressants, a number of studies evaluating the prevalence of cardiac valvular pathology in such individuals have been published. These studies generally support the association of fenfluramine/dexfenfluramine with cardiac valvulopathy but with significant differences in risk assessment. The analysis of these studies has… CONTINUE READING


Publications citing this paper.

Similar Papers

Loading similar papers…